Major bleeding during oral anticoagulant therapy associated with factor V activation by factor Xa

A. Maag*, N. van Rein, T.J. Schuijt, W.F. Kopatz, D. Kruijswijk, S. Thomassen, T.M. Hackeng, R.M. Camire, T. van der Poll, J.C.M. Meijers, M.H.A. Bos, C. van't Veer

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)328-338
Number of pages11
JournalJournal of Thrombosis and Haemostasis
Volume20
Issue number2
Early online date23 Nov 2021
DOIs
Publication statusPublished - Feb 2022

Keywords

  • anticoagulants
  • factor V
  • factor X
  • hemorrhage
  • thrombin
  • TISSUE FACTOR PATHWAY
  • PROTEIN-S
  • INHIBITOR-ALPHA
  • COAGULATION
  • RISK
  • PROTHROMBINASE

Cite this